NeuroPace (NPCE) director gets 1,153-share stock grant as board fees
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Kumar Rakhi reported acquisition or exercise transactions in this Form 4 filing.
NeuroPace Inc director Rakhi Kumar received an equity grant of 1,153 shares of Common Stock at $13.00 per share. The shares were issued under the company’s non-employee director compensation policy in lieu of quarterly cash retainer fees, bringing Kumar’s direct holdings to 19,160 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Kumar Rakhi
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,153 | $13.00 | $15K |
Holdings After Transaction:
Common Stock — 19,160 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did NeuroPace (NPCE) director Rakhi Kumar report?
Director Rakhi Kumar reported an acquisition of 1,153 NeuroPace Common Stock shares. The shares were granted as part of non-employee director compensation, not bought in the open market, reflecting routine equity-based board remuneration rather than an active trading decision.
Was the NeuroPace (NPCE) director’s Form 4 transaction an open-market purchase?
No, the transaction was not an open-market purchase. The 1,153 shares were issued pursuant to NeuroPace’s non-employee director compensation policy, replacing quarterly cash retainer fees with stock, and are reported as a grant or award acquisition on Form 4.
What does the transaction code on the NeuroPace (NPCE) Form 4 indicate?
The Form 4 uses transaction code “A,” indicating a grant, award, or other acquisition. In this case, 1,153 Common Stock shares were granted to director Rakhi Kumar as equity compensation in lieu of quarterly retainer fees under the non-employee director compensation policy.